HIVID 0.375 (Hivid 0.375 MG)

Generic Name: zalcitabine

Pill imprint HIVID 0.375 has been identified as Hivid 0.375 MG.

Hivid is used in the treatment of hiv infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Hivid 0.375 MG is not a controlled substance under the Controlled Substance Act (CSA).

Hivid

Generic Name:

zalcitabine

Imprint:

HIVID 0.375

Strength:

0.375 MG

Color:

Pink

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Nucleoside reverse transcriptase inhibitors (NRTIs)

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Roche Laboratories

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.